Diarrheal Episodes — Evaluate the Effect of Planet Water Foundation's Clean Water, Sanitation and Hygiene Intervention
Citation(s)
Cohen J A power primer. Psychol Bull. 1992 Jul;112(1):155-9. doi: 10.1037//0033-2909.112.1.155.
Donner A, Klar N Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemiol. 1996 Apr;49(4):435-9. doi: 10.1016/0895-4356(95)00511-0.
Hartup, WW Peer relations. Handbook of child psychology 1983; 4:103-196.
Kohlberg, L Stage and sequence: The cognitive-developmental approach to socialization. New York: Rand McNally 1969: 347-480.
Liang, K Y., & Zeger, S. L. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
McCulloch, C E., & Searle, S. R. Generalized, linear, and mixed models. New York: John Wiley & Sons 2001.
McCulloch, C E., Searle, S. R., & Neuhaus, J. M.. Generalized, linear, and mixed models. New York: John Wiley & Sons 2008.
Raudenbush, S W. Bryk, A. S. Hierarchical linear models: Applications and data analysis methods. 2nd edition. Newbury Park, CA: Sage 2002.
United Nations (UN) The Millennium Development Goals Report 2013. New York: United Nation, 2013.
Assessing the Health Impact of Safe Water, Sanitation, and Hygiene Education in the Developing World
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
